Novanta Inc.

Novanta Inc. (NOVT) Market Cap

Novanta Inc. has a market capitalization of $5.57B.

Price: $156.29

-8.81 (-5.34%)

Market Cap: 5.57B

NASDAQ · time unavailable

CEO: Matthijs Glastra

Sector: Technology

Industry: Hardware, Equipment & Parts

IPO Date: 1999-03-24

Website: https://www.novanta.com

Novanta Inc. (NOVT) - Company Information

Market Cap: 5.57B|Sector: Technology

Company Profile

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Analyst Sentiment

89%
Strong Buy

From 3 Active Polls

1Y Forecast: $150.00

▼ -4.0% Potential Upside

Consensus Target Metrics

Low Bound

$150

Median

$150

High Bound

$150

Average

$150

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$150.00
▼ -4.02% Upside
Low Target
$150.00
-4% Risk
Median Target
$150.00
-4% Mid
High Target
$150.00
-4% Max
Consensus
Buy
2 / 3 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MApr 3, 2026Dec 31, 2025Sep 26, 2025Jun 27, 2025Mar 28, 2025Dec 31, 2024Sep 27, 2024Jun 28, 2024
Market Cap ($M)5,5664,7314,5503,6344,6834,6505,4976,3465,863
Enterprise Value ($M)5,4684,6344,5114,0505,0864,9865,8546,7676,302
Price to Earnings Ratio (P/E)117.6156.0665.1185.28260.3354.8183.4682.66106.56
Price/Earnings-to-Growth Ratio (PEG)15.3530.2979.0722.8349.73
Price to Sales Ratio (P/S)5.5418.3617.6114.6619.4319.9323.0925.9624.86
Price to Book Ratio (P/B)4.823.613.464.535.846.047.378.558.35
Price to Free Cash Flow Ratio (P/FCF)82.82102.47886.39862.71400.79169.7192.67326.00162.15
Enterprise Value to Sales (EV/Sales)17.9817.4616.3421.1021.3724.5927.6926.72
Enterprise Value to EBITDA (EV/EBITDA)30.49104.5994.4391.55118.11114.55123.35137.52148.72
Debt to Equity Ratio-0.540.220.260.630.640.570.630.690.77

NOVT Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$156.29
Intrinsic Value$87.58
Market Alignment
Overvalued by 44.0%relative to calculated intrinsic value
9.00%
Exp: 1%1%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.16B
Perpetuity TV Value$3.00B
Discounted TV (PV)$1.27B
TV Weighting %57.9%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 NOVANTA INC (NOVT) — Investment Overview

🧩 Business Model Overview

NOVANTA designs and manufactures precision-engineered subsystems used in advanced industrial and scientific equipment. The value chain centers on (1) application-specific engineering, (2) production of high-precision components and modules (often involving optics, sensors, actuators, and motion control), and (3) integration into customer platforms such as semiconductor manufacturing tools, automation systems, and metrology/inspection workflows. Customers typically qualify these subsystems through extensive performance testing and then deploy them as part of a larger installed system, creating a long-term service and replacement cycle.

💰 Revenue Streams & Monetisation Model

Revenue is primarily product-led, with a meaningful recurring component coming from ongoing service, support, and lifecycle needs after system qualification. Monetisation drivers include (1) the ability to engineer differentiated solutions rather than selling commodity components, and (2) maintaining service relationships with customers that already run NOVANTA-enabled equipment. Margin performance tends to be supported by higher-value engineered content, strong gross margin discipline inherent to precision manufacturing, and operating leverage as demand pulls through factory utilization and supply chain execution.

🧠 Competitive Advantages & Market Positioning

Primary moat: Switching costs via qualification + installed base. Competitors can offer functionally similar parts at the component level, but replacing a qualified subsystem in a production-grade environment is costly and risky. Customers face downtime, re-qualification, system performance verification, and engineering effort to ensure process stability. Over time, the installed base and the application-specific know-how embedded in the solution create high practical switching costs.

Secondary moat: Intangible assets in precision engineering and application expertise. NOVANTA’s differentiation is reinforced by engineering capabilities (tolerances, calibration, optical/mechatronic integration), manufacturing quality systems, and deep customer application understanding—assets that are difficult to replicate quickly without significant time, investment, and validation.

  • Competitive benchmarking:
  • Coherent (photonics and lasers): broader photonics exposure, often competing at the component/optics layer; NOVANTA’s positioning is more aligned with engineered subsystems and integrated precision platforms across automation and scientific equipment.
  • Aerotech (precision motion control): strong in motion solutions; NOVANTA typically competes with a wider precision portfolio that can address integrated motion/optics/sensing needs within customer systems.
  • Cognex (machine vision): strong in vision hardware/software; NOVANTA’s focus is more on precision optical/mechatronic subsystems used in demanding industrial and technical instrumentation contexts, where integration and qualified performance are critical.

NOVANTA’s industry focus spans high-spec automation, semiconductor-related workflows, and scientific/inspection use cases. This contrasts with rivals that may be more concentrated in one end-market or one component layer, leaving NOVANTA better positioned where system qualification and precision performance matter more than substitutable general-purpose hardware.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the growth profile is tied to persistent capital spending themes that expand the need for precision automation and high-throughput inspection:

  • Semiconductor and electronics complexity: As devices scale and packaging/interconnect complexity rises, equipment requires improved precision, stability, and measurement/inspection capability—raising demand for qualified subsystems.
  • Industrial automation and quality control: Labor constraints and the need for yield improvement support more automation and more frequent inspection, increasing penetration of precision motion, sensing, and optical subcomponents.
  • Metrology and advanced inspection: Tighter tolerances drive demand for equipment that can measure and verify performance reliably, supporting sustained replacement and expansion cycles after qualification.
  • Lifecycle expansion: Once deployed, customers tend to extend system upgrades and maintenance using the incumbent ecosystem, supporting revenue continuity through service and replacement demand.

The TAM expands not only through unit growth in automation equipment, but also through higher “precision content” per tool and per production line as tolerances tighten and inspection requirements broaden.

⚠ Risk Factors to Monitor

  • End-market capex cyclicality: Semiconductor equipment cycles and industrial automation spending can swing with demand, affecting order pacing.
  • Competition and qualification barriers: Even with switching costs, competitors that successfully clear performance and qualification hurdles can win new programs.
  • Technology and platform shifts: Architectural changes in customer tool design (including alternative sensing/actuation approaches) can alter performance requirements.
  • Manufacturing execution and supply chain concentration: Precision manufacturing is sensitive to component availability, lead times, and quality controls; disruptions can impact delivery performance.
  • Integration risk from acquisitions: If growth is supported by inorganic activity, integration of products, quality systems, and commercial structures can influence long-run margin outcomes.

📊 Valuation & Market View

Equity markets typically value NOVANTA and similar industrial precision businesses using EV/EBITDA and growth-oriented multiples that reward (1) margin durability, (2) operating leverage potential from scale, and (3) evidence of durable demand in end markets with long equipment qualification cycles. Price-to-sales frameworks can also be used when investors emphasize engineered content and recurring service attachment, but the multiple usually becomes more sensitive to margin trajectory, backlog/visibility signals, and confidence in end-market conversion rather than purely top-line growth.

🔍 Investment Takeaway

NOVANTA’s long-term investment case rests on precision-engineered differentiation backed by high practical switching costs stemming from qualification, installed-base familiarity, and application integration. As semiconductor and industrial systems demand tighter tolerances and higher inspection/automation intensity, NOVANTA’s engineered subsystem portfolio is positioned to capture share through program wins and lifecycle demand—while investors should monitor end-market cyclicality, qualification dynamics, and execution risk in manufacturing and integration.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for NOVT.

gurufocus.com2026-05-22

A Look at Novanta Inc (NOVT) After 3.1% Gain -- GF Value $154.22 vs Price $159.70

On May 22, 2026, Novanta Inc (NOVT) shares rose 3.1% to $159.70, reflecting a positive price movement amid a strong performance over the past month and year. Th

gurufocus.com2026-05-20

A Look at Novanta Inc (NOVT) After 4.0% Gain -- GF Value $154.26 vs Price $153.60

On May 20, 2026, Novanta Inc (NOVT) shares rose 4.0% today, bringing the current price to $153.60. The stock has experienced a 52-week range of $98.27 to $165.5

zacks.com2026-05-20

Here's Why Novanta (NOVT) Looks Ripe for Bottom Fishing

Novanta (NOVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

businesswire.com2026-05-15

Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive.

businesswire.com2026-05-15

Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.

seekingalpha.com2026-05-12

Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript

marketbeat.com2026-05-12

Novanta Q1 Earnings Call Highlights

Novanta NASDAQ: NOVT reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and rising exposure to artificial intelligence-related infrastructure applications.

zacks.com2026-05-11

Novanta (NOVT) Q1 Earnings and Revenues Surpass Estimates

Novanta (NOVT) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.74 per share a year ago.

businesswire.com2026-05-11

Novanta Announces Financial Results for the First Quarter 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2026. Financial Highlights Three Months Ended   (In millions, except per share amounts) April 3,     March 28,     2026     2025   GAAP           Revenue $ 257.7     $ 233.4   Operating Income $ 27.5     $ 32.4   Net Income $ 21.1     $ 21.2   Diluted EPS $ 0.51     $ 0.5.

gurufocus.com2026-04-29

Novanta Inc (NOVT) Shares Fall 6.3% -- What GF Score of 92 Tells Investors

On April 29, 2026, Novanta Inc (NOVT) shares fell 6.3% to $120.89. This decline comes amid a 52-week range of $98.27 to $149.95, reflecting notable volatility.

businesswire.com2026-04-14

Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference c.

defenseworld.net2026-03-31

Novanta Inc. $NOVT Shares Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 75.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,399,462 shares of the technology company's stock after purchasing an additional 604,055

defenseworld.net2026-03-24

Congress Asset Management Co. Has $72.82 Million Position in Novanta Inc. $NOVT

Congress Asset Management Co. raised its stake in Novanta Inc. (NASDAQ: NOVT) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 611,978 shares of the technology company's stock after buying an additional 21,331 shares during the quarter. Congress

businesswire.com2026-03-16

Novanta Joins NVIDIA Halos AI Systems Inspection Lab

BOSTON--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) announced today that it has joined NVIDIA Halos AI Systems Inspection Lab, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. The lab helps accelerate certification and advance trust in key components and subsystems enabling the next generation of robotics and physical AI systems. By participating in Halos AI Systems Inspection Lab, Novanta will work with NVIDIA to validate the interop.

defenseworld.net2026-03-13

Capital International Investors Sells 620,843 Shares of Novanta Inc. $NOVT

Capital International Investors reduced its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 82.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,552 shares of the technology company's stock after selling 620,843 shares during the quarter. Capital

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-04-03

"NOVT reported Q1 2026 revenue of $257.7M and net income of $21.1M (EPS: $0.52). Revenue was up +1.3% QoQ (vs. $258.3M in Q4 2025) and +10.3% YoY (vs. $233.4M in Q1 2025). Net income increased +20.8% QoQ (from $17.5M) and +−0.0% YoY (essentially flat vs. $21.2M in Q1 2025). Margins weakened over the quarter: net margin contracted to 8.2% from 6.8% in Q4 (improved QoQ) but was slightly below the earlier Q1 2025 level (9.1%), while operating margin rose to 10.7% from 18.4% in Q4—indicating a notable reversal in operating profitability. Balance sheet resilience remains strong: total assets were $1.80B with equity at $1.31B. Cash and cash equivalents were $388.8M, and net debt improved markedly to -$110.1M (net cash) from -$39.3M at Q4 2025, reflecting balance sheet strengthening and/or deleveraging. Cash flow quality looks solid in the quarter with operating cash flow of $51.6M and free cash flow of $47.5M. Shareholder returns are supported by the stock’s momentum (1y change +13.0%; 6m +20.9%), but there is no evidence of a very strong >20% 1-year rally. No dividends were paid; repurchases occurred ($18.6M in Q1)."

Revenue Growth

Positive

Q1 2026 revenue of $257.7M grew +1.3% QoQ and +10.3% YoY, showing steady top-line expansion.

Profitability

Fair

Net margin was 8.2% in Q1 2026 vs 6.8% QoQ improvement, but down vs 9.1% YoY; operating margin signals volatility (10.7% in Q1 2026 vs 18.4% in Q4 2025). EPS was $0.52 vs $0.59 in Q1 2025 (YoY down).

Cash Flow Quality

Positive

Operating cash flow was $51.6M and free cash flow $47.5M in Q1 2026, supporting earnings with strong cash conversion for the quarter; no dividends (payout ratio 0).

Leverage & Balance Sheet

Good

Total equity held up at $1.31B and net debt improved to net cash (-$110.1M) from net cash (-$39.3M) in Q4 2025, indicating improved financial resilience.

Shareholder Returns

Fair

Capital appreciation is positive (1y +13.0%, 6m +20.9%) and Q1 included buybacks (-$18.4M), but no dividend yield and the 1-year momentum is below a >20% threshold.

Analyst Sentiment & Valuation

Fair

Consensus price target is $150 vs current price $128.85 (moderate upside). Valuation metrics remain rich (e.g., price-to-sales ~18x and high P/E), which tempers the score despite operational progress.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Novanta’s Q1 2026 shows strong demand and execution: bookings rose 37% YoY (book-to-bill 1.10) with revenue +10% reported (+3% organic) and broad-based double-digit bookings/revenue growth across segments. Profitability improved materially—adjusted EBITDA +14% YoY and margin expansion of +70 bps—alongside exceptional cash performance (operating cash flow +63% YoY; >200% cash conversion to net income). The main negative is gross margin timing: adjusted gross margin fell 60 bps YoY to 45.6%, driven by freight, tariff, and material cost inflation outpacing surcharges/repricing. Management is actively offsetting costs via pricing actions, backlog repricing, and two facility closures on track for Q2 to drive a gross margin step-up in H2. Guidance was reaffirmed on EBITDA and EPS ranges but raised on GAAP revenue ($1,040m–$1,055m). GenAI-related AI data center exposure is quantified at ~15% of revenue, expected to accelerate through the year.

AI IconGrowth Catalysts

  • Robotics & Automation: bookings up 50% YoY; new product revenue up >70% YoY; GenAI-driven tailwinds supporting precision robotics/warehouse automation
  • Precision Manufacturing: intelligent laser beam steering subsystems launched; AI data center application momentum; Precision Manufacturing returned to mid- to high-single-digit revenue growth
  • Advanced Surgery: next-generation insufflators driving double-digit growth; scalable medical consumables franchise (15% of revenue) growing at sustained double-digit rates
  • Precision Medicine: Keonn acquisition contributed to double-digit growth; life science exposure expected <10% of total revenue in 2026
  • GenAI data center-related applications: ~15% of total company revenue in Q1; grew ~20% YoY with expectation of accelerating growth through the year

Business Development

  • Joined NVIDIA Halos AI Systems Inspection Lab (March 2026), with management stating Novanta is the only servo drive manufacturer selected; certification validates safe AI-driven robotics integration
  • Assumed recurring design-in via OEM collaborative partnerships; exclusivity designed-in product relationships typically last up to a decade (no specific OEM names provided)

AI IconFinancial Highlights

  • Beat expectations: revenue +10% reported growth and +3% organic growth; bookings +37% YoY with book-to-bill 1.10
  • Profitability: adjusted EBITDA +14% YoY; adjusted EBITDA margin +70 bps YoY; adjusted diluted EPS +9% YoY
  • Cash flow strength: operating cash flow +63% YoY; cash conversion to net income >200% in Q1
  • Adjusted gross margin: 45.6% vs 46.0% in Q1 2025; down 60 bps YoY and roughly flat sequentially
  • Margin headwind explained: price/cost timing impact from higher freight, tariff costs, and material costs; rapid geopolitical-driven cost increases outpaced ability to surcharge/reprice
  • Tax: non-GAAP tax rate 19% vs 20% in Q1 2025; decrease due to jurisdictional mix of pretax income
  • EPS and headwinds: adjusted EPS $0.81, includes $0.03 headwind from temporary inflation/tariff impacts
  • Second quarter margin guidance: adjusted gross margins 45.5%–46.0% (flat to modestly ahead sequentially); expects improved second-half margins as surcharging, pricing, and cost actions fully take hold
  • Full-year guidance update: GAAP revenue $1,040m–$1,055m (raised range); adjusted EBITDA $245m–$250m; adjusted EPS $3.50–$3.65

AI IconCapital Funding

  • Share repurchases: purchased approximately $18m of company stock in Q1
  • Balance sheet: gross debt $249m; gross leverage ratio 1.1x; cash balance $389m; net debt negative $139m; net leverage ratio negative 0.6x (net cash position maintained)
  • Capital allocation: acquisitions remain top priority; buybacks continue opportunistically but are tempered by active acquisition pipeline (no total FY buyback authorization disclosed)

AI IconStrategy & Ops

  • Manufacturing foundation: two facility closures on track to complete in Q2; consolidating into fewer centers of manufacturing excellence to support a gross margin step-up in H2
  • Pricing/surcharging actions: implemented product price increases and updated all surcharges to reflect new tariff rates; working to reprice existing backlog
  • Risk management inventory: deliberate safety stock investments in electronic components, rare earth materials, and inventory tied to regional manufacturing routes to avoid part shortages
  • R&D/SG&A cost structure: R&D $23m (~9% of sales), down 1 point YoY; SG&A ex certain adjustments $51m (~20% of sales), flat as % of sales
  • Cash flow target: expects cash flow conversion to net income 100% or better as % of net income for Q2 and full year

AI IconMarket Outlook

  • Organic growth outlook: management expects organic growth to reach high single digits in Q2 and continue acceleration through back half absent deeper macro/geopolitical shift
  • Full-year 2026 organic growth: up to 6% organic (reported growth >7%) within raised GAAP revenue range
  • Q2 guidance: GAAP revenue $259m–$264m; organic growth 6%–8% and reported revenue growth up to 10%
  • Q2 bookings→revenue lag commentary: management reiterated typical 2–3 quarter lag from bookings to revenue

AI IconRisks & Headwinds

  • Gross margin pressure in Q1: freight, tariff costs, and material cost inflation caused price/cost timing mismatch because costs shifted faster than customer surcharging and order repricing
  • Geopolitical and trade dynamics: management cited ongoing complexity affecting input costs and the ability to reprice backlog quickly
  • Tariff refund uncertainty: no benefit from potential U.S. government tariff refunds included in guidance; management views this as a risk buffer if implementation timing shifts
  • Order timing/cycle risk: management noted early-year customer preference for full-year orders and typical bookings-to-revenue lag (2–3 quarters), requiring disciplined guidance updates

Q&A: Analyst Interest

  • Topic: GenAI data center exposure quantification and what it includes: Management clarified that the ~15% of sales, ~20% YoY GenAI-driven portion is a collective spanning Precision Manufacturing and Robotics & Automation applications. It includes DUV/EUV lithography, GPU drilling, probe card production, metrology for 2-nanometer nodes, and precision robotics tailored to advanced wafer fab/advanced industrial uses.
  • Topic: NVIDIA Halos AI Systems Inspection Lab and commercialization timing: Management said Novanta is (to its knowledge) the only servo drive manufacturer selected via a rigorous certification process. The lab certification reduces OEM sub-testing friction, supporting prototype orders. They temper expectations but expect more meaningful impact in 2027 as adoption matures through the cycle.
  • Topic: Reconciling 37% bookings growth vs modest organic revenue growth and order timing: Management stated the majority of orders ship within the next 12 months and emphasized Q1 dynamics: year-over-year against a lower prior-year base, some customers placing full-year orders in Q1, and a typical 2–3 quarter bookings-to-revenue lag. Discipline delayed broader upward revisions until one revenue/profit quarter clears.

Sentiment: MIXED

Note: This summary was synthesized by AI from the NOVT Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for NOVT.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (NOVT)

© 2026 Stock Market Info — Novanta Inc. (NOVT) Financial Profile